Xifaxan
In brief
- In our pharmacy, you can buy Xifaxan without a prescription, with delivery in 9–21 days throughout the United Kingdom. Discreet and anonymous packaging.
- Xifaxan is used for travellers’ diarrhoea, irritable bowel syndrome with diarrhoea (IBS-D, off-label in the UK), and hepatic encephalopathy prevention. It works by inhibiting bacterial RNA synthesis in the gut, reducing harmful bacteria while minimising systemic absorption.
- Usual dosage varies: 200mg three times daily for 3 days (travellers’ diarrhoea), 550mg three times daily for 14 days (IBS-D), or 550mg twice daily for chronic hepatic encephalopathy management.
- The form of administration is oral tablet, available in 200mg and 550mg strengths.
- Onset time is typically 24-48 hours for symptomatic relief, with noticeable improvements in diarrhoea or hepatic symptoms within this period.
- Duration of action requires ongoing dosing for chronic conditions (hepatic encephalopathy), while short courses (3-14 days) suffice for acute issues like travellers’ diarrhoea or IBS-D flare-ups.
- Avoid alcohol consumption, as it may worsen gastrointestinal side effects like nausea and complicate liver conditions.
- The most common side effects include nausea, headache, abdominal pain, flatulence, and bloating.
- Would you like to try Xifaxan without a prescription today to experience fast relief from gastrointestinal symptoms?
Basic Xifaxan information: UK prescribing essentials
| Information type | Details |
|---|---|
| INN (International Nonproprietary Name) | Rifaximin |
| Brand names (UK) | Targaxan (550 mg), Xifaxanta (200 mg) |
| ATC code | A07AA11 (intestinal anti-infectives) |
| Forms and strengths | Film-coated tablets: 200mg and 550mg strengths |
| Manufacturers | Norgine Pharmaceuticals Limited (UK licensee) |
| UK registration status | Rifaximin is licensed (MHRA product database) |
| Legal classification | Prescription-only medicine (POM) |
Xifaxan contains the active ingredient rifaximin, classified as an antibiotic specifically formulated to treat gastrointestinal infections with minimal absorption into the bloodstream. Unlike systemic antibiotics, Xifaxan acts locally within the digestive tract.
Understanding Xifaxan tablets and strengths
The medication comes in two tablet strengths that serve distinct purposes. Patients receive either 200mg tablets for short-term gastrointestinal infections or 550mg tablets for chronic conditions like hepatic encephalopathy.
Treatment courses vary significantly depending on the condition. Short-term travellers’ diarrhoea management typically involves three days of therapy, while hepatic encephalopathy requires ongoing maintenance treatment.
Medical conditions Xifaxan treats in the UK
Rifaximin is used for the following conditions:
- Travellers’ diarrhoea: Caused by non-invasive strains of E. coli (200mg tablets)
- Irritable bowel syndrome with diarrhoea (IBS-D): For symptom reduction in adults (550mg tablets; off-label use in the UK)
- Hepatic encephalopathy: Preventing recurrences in liver disease patients (hepatic encephalopathy)
Unlike conventional antibiotics used for systemic infections, Xifaxan operates within the digestive tract without significant absorption, explaining its specific application for intestinal conditions. The medication helps control bacterial imbalances without widespread impact on gut flora.
Standard dosage regimens in UK practice
Proper dosing depends on the condition being managed. Follow specialist instructions precisely regarding both tablet strength and treatment duration.
| Indication | Adult dosage | Course duration |
|---|---|---|
| Travellers’ diarrhoea | 200mg three times daily | 3 days |
| IBS-D | 550mg three times daily | 14 days (course repeat possible) |
| Hepatic encephalopathy prevention | 550mg twice daily | Ongoing maintenance |
The 200mg and 550mg tablets are prescribed for different indications and are not used interchangeably.
Xifaxan dosing for vulnerable individuals
Special considerations apply to certain patient groups receiving Xifaxan prescriptions under NHS guidance:
| Patient group | Dosing considerations |
|---|---|
| Children and adolescents | Not recommended under 18 years |
| Elderly patients | Standard dosing |
| Severe liver impairment | Requires specialist supervision despite low absorption |
| Kidney dysfunction | No dosage adjustment required |
Cautious prescribing applies particularly to hepatic encephalopathy patients with advanced liver disease. Ongoing monitoring ensures safety despite Xifaxan’s low systemic availability.
Administration guidance and storage
Proper tablet management ensures effective treatment. Take tablets with or without food unless explicitly instructed otherwise. Swallow whole – crushing or chewing affects medication release.
If forgetting a dose, take when remembered unless approaching next scheduled dose. Never take a double dose to compensate. Seek immediate medical advice for excessive accidental consumption though risks seem low due to limited absorption.
Store tablets below 25°C in their original packaging. Avoid damp environments like bathrooms and securely lock away from children. Return unused medicines to a pharmacy for safe disposal.
What exactly is Xifaxan and when would a doctor prescribe it?
Xifaxan (rifaximin) is an antibiotic medication primarily used to treat specific gut-related conditions by targeting bacteria locally in the intestines. Unlike many antibiotics absorbed into the bloodstream, its action stays focused within the digestive tract. In the UK, this prescription-only medicine isn’t typically first-line but serves key roles:
- Managing hepatic encephalopathy (HE): Prescribed long-term to prevent recurring episodes of confusion or brain fog linked to severe liver disease.
- Treating travellers’ diarrhoea: Used short-term (3 days) for uncomplicated cases caused by non-invasive E. coli bacteria when systemic antibiotics aren’t required.
- Reducing IBS-D symptoms: Used off-label in 14-day courses for irritable bowel syndrome with predominant diarrhoea when other measures fail.
Xifaxan addresses bacterial causes without significant body-wide absorption, making it distinct from drugs like metronidazole or ciprofloxacin. Patients usually receive it as 550mg tablets for HE/IBS-D or 200mg tablets for diarrhoea.
How Xifaxan works inside your digestive system
Rifaximin stops sensitive gut bacteria from growing by blocking their RNA synthesis (bacterial RNA polymerase). Since only about 0.4% enters systemic circulation, it acts locally – minimising risks like systemic antibiotic resistance or disruption to body-wide bacterial balance. This makes Xifaxan valuable for recurring gut conditions needing repeated treatment. Unlike laxatives or anti-diarrhoeals that just manage symptoms, rifaximin targets bacterial triggers in the bowel lumen. Its effectiveness shows as reduced ammonia production by gut bacteria (critical in HE) or decreased inflammation triggering diarrhoea-predominant IBS.
Who should avoid Xifaxan: contraindications and precautions
Xifaxan isn’t safe for everyone. Key restrictions include:
- Allergy to rifamycins: Complete avoidance necessary if previously reacting to rifampicin, rifabutin, or rifapentine.
- Severe bloody diarrhoea or high fever: Not suitable; may indicate infections like Shigella or C. difficile needing different antibiotics.
- Intestinal obstruction: Risk of tablet accumulation causing complications.
Special caution applies with severe liver impairment despite its hepatic encephalopathy indication – careful monitoring remains crucial. In inflammatory bowel disease flares, professional advice is essential before use. Never take Xifaxan prescribed for someone else or repurpose leftovers.
Common and serious side effects of Xifaxan therapy
Although minimally absorbed, rifaximin still causes side effects. Gastrointestinal reactions prevail including nausea, bloating, constipation and abdominal pain in over 5% of users. Headache, fatigue and peripheral swelling occur less frequently. Rashes or itching suggest possible hypersensitivity – requiring immediate discontinuation. Increased diarrhoea or bloody stools could signal C. difficile infection or worsening infection; these warrant urgent consultation. Liver function changes (rare) necessitate monitoring in cirrhotic patients using rifaximin long-term.
Managing adverse reactions while still getting relief
For mild nausea, taking tablets with bland food often helps without impacting absorption. Persistent bloating may improve with smaller meals and reduced fibre temporarily during treatment. For headaches, standard analgesics can be used appropriately – consult pharmacists about interactions. Key warnings requiring prompt medical assessment include:
- Severe abdominal pain or bloody stool (possible worsening infection)
- Skin reactions, breathing difficulties (allergy signs)
- Yellowing skin/eyes indicating liver stress
Side effects management never involves altering dose without approval – report concerns to your GP or pharmacist.
Pregnancy, breastfeeding and Xifaxan safety considerations
Formal studies on rifaximin during pregnancy remain limited. It’s only used when clinicians determine benefits significantly outweigh risks. Trace amounts enter breast milk; effects on infants are unclear. Prescribers typically recommend avoiding breastfeeding during medication courses. Always discuss pregnancy intentions or breastfeeding status with your doctor before starting rifaximin, exploring alternative therapies if appropriate.
Drug interactions: combining rifaximin with other medicines
Due to its low absorption, rifaximin exhibits few interactions – a key advantage over systemic antibiotics. Notable precautions:
- Warfarin: Theoretic interaction with vitamin K produced by gut bacteria; monitor INR more frequently.
- Ciclosporin: May increase rifaximin blood levels.
- Oral contraceptives: Unlike rifampicin, rifaximin doesn’t reduce efficacy, but discuss backup methods when treating diarrhoea.
Regardless of limited known interactions, disclosing all medications (including supplements and herbal remedies) to healthcare providers remains essential.
Frequently asked questions about Xifaxan usage
Does rifaximin permanently cure IBS?
Why take Xifaxan if it’s not absorbed?
Can you drink alcohol during treatment?
Over-the-counter alternatives?
Generic availability in the UK?
Alternative treatments comparison
Depending on the condition, several options exist if Xifaxan isn’t suitable. For travellers’ diarrhoea, alternatives include short courses of ciprofloxacin or azithromycin, though these carry more systemic effects. Hepatic encephalopathy management might involve lactulose or neomycin. IBS-D patients might benefit from loperamide for acute symptom control.
